AXL and glomerulonephritis: A study documented the efficacy of CH5451098, a novel AXL inhibitor, in a mouse model of glomerular nephritis, revealing its potential in ameliorating kidney dysfunction by targeting EMT in tubular cells (Kurata et al., 2020).